
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | 700-800 |
| Total Number of Projects: | > 1000 |
| 2019 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2018 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 2
Sole participant: 2
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2022 | 0 | 6.348.927 | 335.950 | 1 | ||
| 2020 | 2.499.125 | 0 | 2.499.125 | 1 | ||
| 2019 | 157.356 | 0 | 157.356 | 1 | ||
| 2018 | 0 | 904.500 | 27.000 | 1 | ||
Total number of partners: 30
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 30
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2022-12-01 | Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies | halt-RONIN | participant | 6.348.927 | 23 |
| 2020-10-01 | Boosting the Rare Disease research and innovation capacity of the Izmir Biomedicine and Genome Center | RareBoost | coordinator | 2.499.125 | 1 |
| 2019-04-01 | Well-Confined Mucosal LasEr Ablation with a Negative Pressure Based Endoscopy Capsule | CLEAN | coordinator | 157.356 | 1 |
| 2018-01-01 | Death receptor signalling in tumour immune editing | DISCOVER | participant | 904.500 | 9 |